Glucotrack, Inc. (Nasdaq: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...

Addressing the imbalance in clinical trial workloads by empowering mid-level investigators and using AI to expand access to ...

NYU Langone’s Center for Multisite Studies is led by experts who are experienced in managing and supporting research.

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that Lyndah K.

SAN FRANCISCO--(BUSINESS WIRE)--Shasqi, a clinical-stage biotechnology company developing click chemistry-activated oncology therapeutics, today announced the additions of Steve Abella, M.D., as Chief ...

We're excited to talk to you! Reach out to us anytime for a consultation on your trial management, protocol development, logistical planning, and regulatory and financial needs. The CRE at the ...

New long-term data of the investigational therapy icotrokinra show that it is able to achieve site-specific clear or almost clear skin in patients with plaque psoriasis, according to results of the ...

"We are thrilled to welcome Dr. Gow to our executive team," said Vish Seshadri, Chief Executive Officer of Abeona. "James has ...